Metabolic syndrome in pediatric renal transplant recipients: Comparing early discontinuation of steroids vs. steroid group

Pediatric Transplantation

Volumn 14, Issue 3, 2010, Pages 351-357

  Maduram, Amy ^a   John, Eunice ^b   Hidalgo, Guillermo ^b   Bottke, Ramona ^b   Fornell, Linda ^b   Oberholzer, Jose ^b   Benedetti, Enrico ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Immunosupressive treatment; Kidney transplantation; Obesity

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; IMMUNOSUPPRESSIVE AGENT; LIPID;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PEDIATRIC SURGERY; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; INCIDENCE; PREVALENCE; RISK FACTOR; UNITED STATES;

CHILD; FEMALE; HUMANS; HYPERTENSION; ILLINOIS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LIPIDS; MALE; METABOLIC SYNDROME X; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS;

EID: 77950652377     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01243.x     Document Type: Article

References (17)

1. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 2002 : 61 : 621 629.
2. Becker-Cohen R, Nir A, Rinant C, et al. Risk factors for cardiovascular disease in children and young adults after renal transplantation. Clin J Am Soc Nephrol 2006 : 1 : 1284 1292.
3. Groothoff JW, Lilien MR, Van de kar NCAJ, et al. Cardiovascular disease as a late complication of end-stage renal disease. Pediatr Nephrol 2005 : 20 : 3740379.
4. Grundy SH, Brewer HB, Cleeman JI. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues related to definition. Circulation 2004 : 109 : 433 438.
5. Duncan GE, Li SM, Zouh X. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care 2004 : 27 : 2438 2443.
6. Morrison JA, Friedman LA, Wang P, et al. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2007 : 152 : 201 206.
7. Hricik DE. Steroid free immunosupression in kidney transplantation: An editorial review. Am J Transplant 2002 : 2 : 19 24.
8. Oberholzer J, John E, Lumpaopong A. Early discontinuation of steroids is safe and effective in pediatric kidney recipients. Pediatr Transplant 2005 : 9 : 436 463.
9. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up? J Pediatr 2008 : 152 : 160 164.
10. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002 : 106 : 100 105.
11. Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008 : 22 : 229 331.
12. Tonshoff B, Hocker B, Weber LT. Steroid withdrawal in pediatric and adult renal transplant recipients. Pediatr Nephrol 2005 : 20 : 409 417.
13. Artz MA, Boots JMM, Ligtenberg G, et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004 : 4 : 937 945.
14. Anantharaman V, Weinberg RB, Schoenberg L, et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989 : 48 : 37 43. (Pubitemid 19194033)
15. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001 : 72 : 13 21.
16. Lorenzo C, Nath SD, Hanley AJG, et al. Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol 2008 : 3 : 783 789.
17. He X, Moore J, Shabir S, et al. Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients. Transplantation 2009 : 87 : 384 392.